MOST NOTEWORTHY:

• Thomas Weisel said Infinera (NASDAQ: INFN) has unique technology that will result in a sustained competitive differentiation, increases customer diversification and improving margins. The firm started shares with an Overweight rating and $13 target.
  
• Dawson Geophysical (NASDAQ: DWSN) was initiated with a Hold rating and $72 target at Jefferies, as they believe the stock is fairly-valued at current levels.
  
• Jesup & Lamont initiated Electro-Optical Sciences (NASDAQ: MELA) with a Buy rating and $8 target. The believes MELA's Melafind is a breakthrough technology for the diagnosis of melanoma.

• Piper resumed coverage of PMI Group (NYSE: PMI) with a Neutral rating and $6 target.
  
• Susquehanna initiated Immunocor (NASDAQ: BLUD) and Given Imaging (NASDAQ: GIVN) with Positive ratings.
  
• Merrill started Liberty Entertainment (NASDAQ: LMDIA) with a Neutral rating.

Analyst initiations: Infinera, Dawson Geophysical, Electro-Optical Sciences originally appeared on BloggingStocks on Wed, 19 Mar 2008 12:02:00 EST. Please see our terms for use of feeds.

Electro Optical Sciences (NASDAQ: MELA) makes a hand-held medical device to assist in the early diagnosis of melanoma (skin cancer). The device emits multiple wavelengths of light when scanning areas of skin and then records differences in skin pigmentation. Such records will assist dermatologists in determining whether a skin lesion is pre-cancerous and/or should be investigated further rather than waiting for the suspicious skin patch to actually manifest skin cancer symptoms. Electro Optical Sciences began clinical trials of the device in January 2007 at 20 different sites. The FDA has agreed to give expedited approval for the device should clinical trial results merit approval. FDA approval could be granted as early as mid 2008.

Electro Optical Sciences currently has neither a commercial product nor revenues. What it does have is a successful record of developing medical imaging devices and then licensing them to suitable companies that have the necessary resources to bring the devices to market. Electro Optical Sciences followed this procedure in bringing to market its DIFOTI device for detecting tooth decay. To date, Electro Optical Sciences has been reluctant to take on debt to finance continued R&D and clinical trials. The company has been financing its research through National Institutes of Health SBA grants as well as by private placement stock sales. The company recently placed another $12 million in stock to continue clinical trials and data interpretation.

This is a stock to keep in the back of one's mind while awaiting the clinical trial results. If those results are positive, look for Electro Optical Sciences to seek a partner, perhaps ASKION, to commercialize the product. Currently, the stock is difficult for individual investors to purchase and is a pure speculative play. The stock currently trades at $5.37. Expect this price to rise or fall dramatically as a result of the clinical trials. Such information on the company as is publicly available can be found at the website: www.eo-sciences.com. The company rarely issues press releases but does file 10-K and 10-Q forms with the SEC.

Electro Optical Sciences (MELA) worth a look originally appeared on BloggingStocks on Wed, 15 Aug 2007 09:30:00 EST. Please see our terms for use of feeds.

The whole series made me think what if someone had written a series like this back in 1982. Many of the names I wrote about I am sure were met with "what's this company?" or " I have never heard of these guys." Back in 1982 I am sure we would have reacted the same way, as many of the future great companies were new or unheard of ... and some did not even exist at that point. As I wrote in the introduction of this series, some of the top 25 stocks may not even be public yet, or even founded for that matter. Google ( NASDAQ: GOOG) was founded in 1998, just 9 years ago and is now a $160 billion market capitalization company!! It has been public for only 3 years.

I am not sure how many of the names I wrote about will be in the top 25 for the NEXT 25 years: only time and performance will tell. But of this I am confident: many of these companies will continue to grow and be more and more relevant in our daily lives. Many will touch us in ways we will never see or truly understand. Not many of us will deal with a large bank and wonder if Opsware (NASDAQ: OPSW) is helping them to automate its massive server farm? Or the next time we slam on our brakes to hopefully avoid an accident, will we really wonder if Wind River Systems (NASDAQ: WIND) designed the real-time operating system micro-chip that helped this automaker design the anti-lock brakes? I doubt it.

Continue reading The top 25 stocks for the NEXT 25 years: 25 for your consideration

The top 25 stocks for the NEXT 25 years: 25 for your consideration originally appeared on BloggingStocks on Fri, 15 Jun 2007 17:28:00 EST. Please see our terms for use of feeds.